• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The role of cytokines in rheumatoid arthritis. The Croonian Lecture 1995.

作者信息

Maini R N

机构信息

Kennedy Institute of Rheumatology, London.

出版信息

J R Coll Physicians Lond. 1996 Jul-Aug;30(4):344-51.

PMID:8875381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5401598/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/6a59c0e4489e/jrcollphyslond90378-0068-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/7d588bee144f/jrcollphyslond90378-0064-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/afba925670cd/jrcollphyslond90378-0065-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/3aa84b060738/jrcollphyslond90378-0065-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/ec3a9de7b3f2/jrcollphyslond90378-0066-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/f1d07812de9f/jrcollphyslond90378-0067-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/233c8d786b0a/jrcollphyslond90378-0068-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/6a59c0e4489e/jrcollphyslond90378-0068-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/7d588bee144f/jrcollphyslond90378-0064-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/afba925670cd/jrcollphyslond90378-0065-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/3aa84b060738/jrcollphyslond90378-0065-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/ec3a9de7b3f2/jrcollphyslond90378-0066-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/f1d07812de9f/jrcollphyslond90378-0067-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/233c8d786b0a/jrcollphyslond90378-0068-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8595/5401598/6a59c0e4489e/jrcollphyslond90378-0068-b.jpg

相似文献

1
The role of cytokines in rheumatoid arthritis. The Croonian Lecture 1995.细胞因子在类风湿关节炎中的作用。1995年克罗尼安讲座
J R Coll Physicians Lond. 1996 Jul-Aug;30(4):344-51.
2
Rheumatoid arthritis and tumor necrosis factor alpha.类风湿性关节炎与肿瘤坏死因子α
Autoimmunity. 2001;34(4):291-303. doi: 10.3109/08916930109014698.
3
[Experimental therapy of rheumatoid arthritis with antibodies to tumor necrosis factor].[用肿瘤坏死因子抗体对类风湿性关节炎进行实验性治疗]
Z Rheumatol. 1998 Oct;57(5):298-301. doi: 10.1007/s003930050115.
4
Role of cytokines in rheumatoid synovitis.细胞因子在类风湿性滑膜炎中的作用。
Recenti Prog Med. 1988 Jul-Aug;79(7-8):318-22.
5
Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behçet's disease.
Clin Exp Rheumatol. 2003 Jul-Aug;21(4 Suppl 30):S57-8.
6
Association of rheumatoid arthritis with multiple sclerosis: report of 14 cases and discussion of its significance.类风湿关节炎与多发性硬化症的关联：14例报告及其意义探讨
J Rheumatol. 2006 May;33(5):1027-8. Epub 2006 Mar 15.
7
[Effects of biologic therapies on systemic osteoporosis in patients with rheumatoid arthritis].[生物疗法对类风湿关节炎患者全身性骨质疏松的影响]
Nihon Rinsho. 2009 May;67(5):996-1002.
8
The prospect for cytokine based therapeutic strategies in rheumatoid arthritis.类风湿关节炎中基于细胞因子的治疗策略前景。
Ann Rheum Dis. 1994 Aug;53(8):485-7. doi: 10.1136/ard.53.8.485.
9
Targeting interleukin-1 in the treatment of rheumatoid arthritis.靶向白细胞介素-1治疗类风湿关节炎。
Arthritis Rheum. 2002 Mar;46(3):574-8. doi: 10.1002/art.10168.
10
[TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].[肿瘤坏死因子抑制剂：风湿病慢性炎症性疾病的一种新治疗视角？]
Z Rheumatol. 1995 May-Jun;54(3):158-64.

引用本文的文献

1
miR-449a inhibits cell proliferation, migration, and inflammation by regulating high-mobility group box protein 1 and forms a mutual inhibition loop with Yin Yang 1 in rheumatoid arthritis fibroblast-like synoviocytes.miR-449a 通过调控高迁移率族蛋白 1 抑制类风湿关节炎成纤维样滑膜细胞的增殖、迁移和炎症反应，并与 Yin Yang 1 形成相互抑制环路。
Arthritis Res Ther. 2019 Jun 3;21(1):134. doi: 10.1186/s13075-019-1920-0.
2
Targeting TNF-alpha with a tetravalent mini-antibody TNF-TeAb.用四价微型抗体TNF-TeAb靶向肿瘤坏死因子-α 。
Biochem J. 2007 Sep 1;406(2):237-46. doi: 10.1042/BJ20070149.
3
Tumour necrosis factor-alpha, interleukin-2 soluble receptor and different inflammatory parameters in patients with rheumatoid arthritis.

本文引用的文献

1
Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.类风湿性滑膜膜细胞培养中促炎细胞因子释放的调节。单克隆抗TNF-α抗体与白细胞介素-1受体拮抗剂的比较。
Eur Cytokine Netw. 1995 Jul-Dec;6(4):225-30.
2
Role of cytokines in rheumatoid arthritis.细胞因子在类风湿关节炎中的作用。
Annu Rev Immunol. 1996;14:397-440. doi: 10.1146/annurev.immunol.14.1.397.
3
Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69.
类风湿关节炎患者的肿瘤坏死因子-α、白细胞介素-2可溶性受体及不同炎症参数
Mediators Inflamm. 2002 Dec;11(6):345-9. doi: 10.1080/0962935021000051539.
4
Infliximab: a review of its use in the management of rheumatoid arthritis.英夫利昔单抗：类风湿关节炎治疗应用综述
Drugs. 2000 Jun;59(6):1341-59. doi: 10.2165/00003495-200059060-00010.
5
No strong association between alleles of tumour necrosis factor alpha and interleukin-1 receptor antagonist and corneal melting associated with systemic vasculitis.肿瘤坏死因子α和白细胞介素-1受体拮抗剂的等位基因与系统性血管炎相关的角膜溶解之间无明显关联。
Br J Ophthalmol. 2000 Apr;84(4):395-8. doi: 10.1136/bjo.84.4.395.
6
The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.类风湿关节炎中的细胞因子网络：将肿瘤坏死因子α定义为治疗靶点
J R Coll Physicians Lond. 1996 Nov-Dec;30(6):560-70.
活化的人T细胞表面表达的细胞表面糖蛋白可诱导单核细胞产生白细胞介素-1β：CD69的可能作用。
Eur Cytokine Netw. 1993 Jan-Feb;4(1):15-23.
4
Twin concordance rates for rheumatoid arthritis: results from a nationwide study.类风湿关节炎的双胞胎一致性率：一项全国性研究的结果。
Br J Rheumatol. 1993 Oct;32(10):903-7. doi: 10.1093/rheumatology/32.10.903.
5
Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection.缺乏55kd肿瘤坏死因子受体的小鼠对内毒素休克具有抗性，但会死于单核细胞增生李斯特菌感染。
Cell. 1993 May 7;73(3):457-67. doi: 10.1016/0092-8674(93)90134-c.
6
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.用抗肿瘤坏死因子α嵌合单克隆抗体治疗类风湿性关节炎。
Arthritis Rheum. 1993 Dec;36(12):1681-90. doi: 10.1002/art.1780361206.
7
Construction and initial characterization of a mouse-human chimeric anti-TNF antibody.小鼠-人嵌合抗TNF抗体的构建及初步表征
Mol Immunol. 1993 Nov;30(16):1443-53. doi: 10.1016/0161-5890(93)90106-l.
8
Immunoregulatory role of interleukin 10 in rheumatoid arthritis.白细胞介素10在类风湿性关节炎中的免疫调节作用。
J Exp Med. 1994 May 1;179(5):1517-27. doi: 10.1084/jem.179.5.1517.
9
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.体外长期暴露于肿瘤坏死因子（TNF）会通过T细胞受体/CD3复合物损害T细胞的激活；类风湿性关节炎患者体内抗TNF抗体可使其逆转。
J Clin Invest. 1994 Aug;94(2):749-60. doi: 10.1172/JCI117394.
10
Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.肿瘤坏死因子α单克隆抗体（cA2）对类风湿性关节炎患者的重复治疗。
Lancet. 1994 Oct 22;344(8930):1125-7. doi: 10.1016/s0140-6736(94)90632-7.